Breakthrough Therapeutics for CLL and Other B-Cell Malignancies: Focus on BTK Inhibitors From Development to Clinical Integration

Learn from expert faculty as they discuss recent and emerging data in chronic lymphocytic leukemia and mantle cell lymphoma including a downloadable slideset from a satellite symposium and an on-demand webcast.

Share

Program Content

Activities

B-Cell BTKi Breakthroughs
Breakthrough Therapeutics for CLL and Other B-Cell Malignancies: Focus on BTK Inhibitors From Development to Clinical Integration
Video
Congratulations: You achieved a completion on 04/09/2022

Released: January 31, 2023

Expires: January 30, 2024

View Activity

Activities

BTKi for Frontline CLL/SLL
Therapy Selection for CLL/SLL in the Frontline Setting
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

View Activity
BTKi for R/R CLL/SLL
Treatment of Relapsed/Refractory CLL/SLL
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

View Activity
BTKi for MCL
Overview of Treatment for Mantle Cell Lymphoma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

View Activity
BTKi Overview
Review of Current and Emerging BTK Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

View Activity
<i>EP</i>: BTKi for CLL and B-Cell Malignancies
ExpressPoints:
Breakthrough Therapeutics for CLL and Other B-Cell Malignancies: Focus on BTK Inhibitors From Development to Clinical Integration
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2022

Expires: December 15, 2023

View Activity

Faculty

cover img faculity

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

cover img faculity

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

cover img faculity

Ian W. Flinn, MD, PhD

Chief Scientific Officer
One Oncology and Tennessee Oncology
Nashville, Tennesse

cover img faculity

Ian W. Flinn, MD, PhD

Director
Lymphoma Research Program
Sarah Cannon Research Institute
Program Director
Sarah Cannon Center for Blood Cancer
Tennessee Oncology
Nashville, Tennessee

cover img faculity

Susan M. O Brien, MD

Professor of Medicine
Department of Leukemia
University of Texas M.D. Anderson Cancer Center
Houston, Texas

cover img faculity

Susan M. O'Brien, MD

Professor
Division of Hematology/Oncology
School of Medicine
University of California, Irvine
Orange, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

BeiGene Ltd

Lilly